01 1American Pacific Corporation
02 1Catalent Micron Technologies, Inc.
03 1Sigma Aldrich Corporation
01 3Sotorasib
01 3U.S.A
NDC Package Code : 50683-0573
Start Marketing Date : 2021-11-17
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69988-0057
Start Marketing Date : 2020-03-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 58272-065
Start Marketing Date : 2021-05-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Sotorasib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sotorasib, including repackagers and relabelers. The FDA regulates Sotorasib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sotorasib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sotorasib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sotorasib supplier is an individual or a company that provides Sotorasib active pharmaceutical ingredient (API) or Sotorasib finished formulations upon request. The Sotorasib suppliers may include Sotorasib API manufacturers, exporters, distributors and traders.
click here to find a list of Sotorasib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sotorasib as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sotorasib API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sotorasib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sotorasib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sotorasib NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sotorasib suppliers with NDC on PharmaCompass.
We have 3 companies offering Sotorasib
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
